Kim Hyung Cheol

Title: Kim Hyung Cheol: Innovator in Carbamate Compounds

Introduction

Kim Hyung Cheol is a notable inventor based in Taejon, South Korea. He has made significant contributions to the field of chemistry, particularly in the development of carbamate compounds. His work focuses on creating effective solutions for central nervous system disorders.

Latest Patents

Kim Hyung Cheol holds a patent for "Carbamate compounds having N-substituted thiocarbamoyl group and process." This patent includes the innovative 3-N-substituted thiocarbamoyl-2-phenyl-1,3-propanediol carbamate. This compound is particularly effective for the prophylaxis and treatment of various central nervous system disorders, including nervous muscular pain, epilepsy, and cerebral apoplexy. The structural formula of the compound is represented as follows: ##STR1##. The components R1 and R2 are selected from a specific group, ensuring that they are not both hydrogen and that the total number of carbon atoms ranges from 1 to 16.

Career Highlights

Kim Hyung Cheol is associated with Yukong Limited, where he continues to innovate and develop new compounds. His work has garnered attention for its potential impact on medical treatments and therapies.

Collaborations

He collaborates with talented coworkers, including Choi Yong Moon and Han Dong Il, who contribute to his research and development efforts.

Conclusion

Kim Hyung Cheol's contributions to the field of carbamate compounds highlight his innovative spirit and dedication to improving medical treatments. His work is paving the way for advancements in the treatment of central nervous system disorders.